Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_assertion type Assertion NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_head.
- NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_assertion description "[Our results demonstrate that PI3K/Akt and GSK-3? prevents in a differential fashion the malignant phenotype of HCT-116 colorectal cancer cells, which could constitute a potential therapeutic target for treatment of this cancer type.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_provenance.
- NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_assertion evidence source_evidence_literature NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_provenance.
- NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_assertion SIO_000772 20204404 NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_provenance.
- NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_assertion wasDerivedFrom befree-20150227 NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_provenance.
- NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_assertion wasGeneratedBy ECO_0000203 NP436526.RAfG-Kq9QfbaveeMOlEp8GCTWO2v7eqoWCZiDLuYV5pE4130_provenance.